pI: 5.3095 |
Length (AA): 514 |
MW (Da): 59119 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
3 | 514 | 1tt5 (A) | 6 | 534 | 28.00 | 0 | 1 | 1.36601 | -0.57 |
3 | 161 | 1zfn (B) | 2 | 164 | 19.00 | 0.0000037 | 1 | 0.625239 | -0.53 |
326 | 451 | 2jqq (A) | 116 | 243 | 28.00 | 0.88 | 0.86 | 0.595936 | -0.74 |
351 | 489 | 2a19 (C) | 285 | 473 | 32.00 | 0.75 | 0.49 | 0.330228 | 1.2 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | Trophozoite, Rahman HM-1 IMSS Trophozoite. | Hon CC |
Hon CC | Transcriptomics of virulent and avirulent strains |
Ortholog group members (OG5_128412)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT2G32410 | AXR1-like protein |
Arabidopsis thaliana | AT1G05180 | RUB-activating enzyme E1 |
Brugia malayi | Bm1_02035 | ThiF family protein |
Candida albicans | CaO19.6299 | similar to S. pombe uba5 (SPAC323.06c) ubiquitin activating enzyme and to S. cerevisiae ULA1 (YPL003W) |
Candida albicans | CaO19.13678 | similar to S. pombe uba5 (SPAC323.06c) ubiquitin activating enzyme and to S. cerevisiae ULA1 (YPL003W) |
Candida albicans | CaO19.11630 | Required for activation of RUB1 |
Candida albicans | CaO19.4153 | Required for activation of RUB1 |
Caenorhabditis elegans | CELE_C26E6.8 | Protein ULA-1 |
Dictyostelium discoideum | DDB_G0287965 | NEDD8-activating enzyme E1 regulatory subunit |
Drosophila melanogaster | Dmel_CG7828 | beta-Amyloid precursor protein binding protein 1 |
Echinococcus granulosus | EgrG_000928200 | NEDD8 activating enzyme E1 regulatory subunit |
Entamoeba histolytica | EHI_000900 | ThiF family protein |
Echinococcus multilocularis | EmuJ_000928200 | NEDD8 activating enzyme E1 regulatory subunit |
Homo sapiens | ENSG00000159593 | NEDD8 activating enzyme E1 subunit 1 |
Leishmania braziliensis | LbrM.33.2930 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_332790.1 | hypothetical protein, conserved |
Leishmania infantum | LinJ.33.2790 | hypothetical protein, conserved |
Leishmania major | LmjF.33.2650 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.32.2650 | hypothetical protein, conserved |
Loa Loa (eye worm) | LOAG_07183 | hypothetical protein |
Mus musculus | ENSMUSG00000031878 | NEDD8 activating enzyme E1 subunit 1 |
Neospora caninum | NCLIV_033670 | GF23890, related |
Oryza sativa | 4334591 | Os03g0820100 |
Saccharomyces cerevisiae | YPL003W | Ula1p |
Schistosoma japonicum | Sjp_0300910 | ko:K04532 amyloid beta precursor protein binding protein 1, putative |
Schistosoma mansoni | Smp_087920 | app binding protein |
Schmidtea mediterranea | mk4.003613.06 | Putative app binding protein |
Trypanosoma brucei gambiense | Tbg.972.2.2220 | ubiquitin activating enzyme, putative |
Trypanosoma brucei | Tb927.2.4020 | NEDD8-activating enzyme E1 regulatory subunit, putative |
Trypanosoma congolense | TcIL3000_2_550 | ubiquitin activating enzyme, putative |
Trypanosoma congolense | TcIL3000_0_39080 | ubiquitin activating enzyme, putative |
Trypanosoma cruzi | TcCLB.504157.90 | NEDD8-activating enzyme E1 regulatory subunit, putative |
Toxoplasma gondii | TGME49_274070 | ThiF family protein |
Trichomonas vaginalis | TVAG_357810 | ubiquitin-activating enzyme E1, putative |
Trichomonas vaginalis | TVAG_457880 | ubiquitin-activating enzyme E1, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.2.4020 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.2.4020 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.2.4020 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb927.2.4020 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_C26E6.8 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_C26E6.8 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_C26E6.8 | Caenorhabditis elegans | slow growth | wormbase |
CELE_C26E6.8 | Caenorhabditis elegans | sterile | wormbase |
TGME49_274070 | Toxoplasma gondii | Probably essential | sidik |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | NEDD8 activating enzyme E1 subunit 1 | Compounds | References |